Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.480
-0.100 (-6.33%)
Feb 26, 2026, 2:40 PM EST - Market open
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $67.87 million as of February 26, 2026. Its market cap has decreased by -25.70% in one year.
Market Cap
67.87M
Enterprise Value
61.83M
1-Year Change
-25.70%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has decreased from $71.77M to $67.87M, a decrease of -5.44%. That is a compound annual growth rate of -0.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 72.45M | -18.56% |
| Dec 31, 2025 | 88.96M | 13.93% |
| Dec 31, 2024 | 78.08M | 351.66% |
| Dec 29, 2023 | 17.29M | -17.80% |
| Dec 30, 2022 | 21.03M | -74.04% |
| Dec 31, 2021 | 81.03M | 308.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 77.97M |
| Pliant Therapeutics | 76.52M |
| PolyPid | 76.09M |
| eXoZymes | 74.85M |
| Pelthos Therapeutics | 74.45M |
| ImageneBio | 74.02M |
| Adicet Bio | 73.78M |
| XBiotech | 72.87M |